SLAMF7 and Miyoshi myopathy: In our study, to investigate the immune attack efficacy of the CS1/CRT vaccine on myeloma cells in a short term, 5-week-old male BALB/c mice were challenged with OPM2 cells (the human MM cell line, which express high levels of CS1) to establish a human plasmacytoma xenograft mouse model.